COVID-19 Implications for I-O Patient Management

​Most companies have made a statement about their position and contributions against the pandemic; including:

Novartis: https://www.novartis.com/coronavirus

Lilly: https://www.lilly.com/news/stories/coronavirus-covid19-global-response

Genentech: https://www.gene.com/covid19

AstraZeneca: https://www.astrazeneca.com/media-centre/articles/2020/our-update-on-covid-19.html

Pfizer: https://www.pfizer.com/health/coronavirus

BMS: https://www.bms.com/about-us/responsibility/coronavirus-updates.html

GSK: https://www.gsk.com/en-gb/media/resource-centre/our-contribution-to-the-fight-against-2019-ncov/

Merck: https://www.mrknewsroom.com/news-release/corporate-news/merck-donates-half-million-masks-support-covid-19-emergency-response-new

Bayer: https://www.bayer.com/en/coronavirus-covid-19-update.aspx

 

 

 

 

 

------------------------------
Fernanda Arnaldez MD
Executive Director, Global Clinical Development
MacroGenics, Inc.
Rockville MD
------------------------------